SNX9 Orchestrates Lung Metastasis via EGFR-ERK Signaling and Actin Cytoskeleton Remodeling in Breast Cancer
Clinically, SNX9 qualifies as a promising prognostic classifier and a rational target for therapeutic intervention and is established as a critical oncoprotein that drives BC progression by coordinating proliferative epidermal growth factor receptor (EGFR)/extracellular signal-regulated kinase 1/2 signaling and cytoske...